AVIDITY BIOSCIENCES
Live / Registered — Registered (as of 15 Sept 2020)
What this means for you
Registered since 15 Sept 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88808590
- Registration number
- 6151953
- Mark type
- Design + words
- Filed
- 24 Feb 2020
- Published for opposition
- 30 Jun 2020
- Registered
- 15 Sept 2020
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields, namely, research and development for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; research and development for the use of antibody-oligonucleotide conjugates for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical and scientific research services for the use of antibody-oligonucleotide conjugates for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; development of pharmaceutical preparations and medicines, namely, the development of oligonucleotide-based therapeutics
Owner
- Avidity Biosciences, Inc., San Diego, CA, US
- Avidity Biosciences, Inc., La Jolla, CA, US
- Avidity Biosciences, Inc., La Jolla, CA, US
Prosecution history
- 05 Mar 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Mar 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 05 Mar 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 05 Mar 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 05 Mar 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 15 Sept 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 05 Sept 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Sept 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 05 Sept 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 05 Sept 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 05 Sept 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 18 Feb 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 18 Feb 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 Feb 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 18 Feb 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED